Leukemia Relapse via Genetic Immune Escape after Allogeneic Hematopoietic Cell Transplantation

Through a broad immunogenetic study, scientists demonstrated that germline and somatic reduction of human leucocyte antigen heterogeneity enhanced the risk of leukemic recurrence.